CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND
Am J Epidemiol
.
2024 Jan 8;193(1):227-231.
doi: 10.1093/aje/kwad179.
Authors
Elsie M F Horne
,
William J Hulme
,
Ruth H Keogh
,
Tom M Palmer
,
Elizabeth J Williamson
,
Edward P K Parker
,
Venexia M Walker
,
Rochelle Knight
,
Yinghui Wei
,
Kurt Taylor
,
Louis Fisher
,
Jessica Morley
,
Amir Mehrkar
,
Iain Dillingham
,
Sebastian Bacon
,
Ben Goldacre
,
Jonathan A C Sterne
,
For The OpenSAFELY Collaborative
PMID:
37656609
PMCID:
PMC10773473
DOI:
10.1093/aje/kwad179
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Vaccines*
COVID-19* / epidemiology
COVID-19* / prevention & control
England / epidemiology
Humans
Substances
COVID-19 Vaccines
Grants and funding
MC_PC_20051/MRC_/Medical Research Council/United Kingdom
MR/V015737/1/MRC_/Medical Research Council/United Kingdom
222097/Z/20/Z/WT_/Wellcome Trust/United Kingdom
MR/S017968/1/MRC_/Medical Research Council/United Kingdom
MR/W021358/1/MRC_/Medical Research Council/United Kingdom
WT_/Wellcome Trust/United Kingdom